Concepedia

Author

Adriana Teixeira

Hospitais da Universidade de CoimbraORCID

Also Known As

A. Teixeira, AMANDA JULIA TEIXEIRA, Adriana C Teixeira, Adriana Corrêa de Souza Teixeira, Adriana Teixeira, Agatha Sousa Teixeira, Alessa Alves Azevedo Teixeira, Alexandre Jacintho Teixeira

64

Publications

2.3K

Citations

12

H-Index

23

Concepts

All Affiliations

Hospitais da Universidade de CoimbraMedical University of ViennaJanssen (United Kingdom)Russian Cancer Research Center NN BlokhinNational and Kapodistrian University of Athens
AT

About

Adriana Teixeira is an author at Hospitais da Universidade de Coimbra specializing in medicine, radiation oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

2K

2

Health Sciences

2

2

233

3

Immunology

2

2

149

4

Biochemistry

1

1

35

5

Cell Biology

1

1

17

Adriana Teixeira

×

12

Publications

2.3K

Citations

11

H-Index

YearCitations

Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.

B Coiffier, E.A. Osmanov, Xin Hong,

The Lancet Oncology

2011

1.6K

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko,

The Lancet Oncology

2018

132

A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma

Maria Teresa Petrucci, Pilar Giraldo, Paolo Corradini,

British Journal of Haematology

2013

123

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

Bertrand Coiffier, Evgenii A. Osmanov, Xiaonan Hong,

The Lancet Oncology

2011

108

Cerebellar thiol status and motor deficit after lactational exposure to methylmercury

Jeferson Luís Franco, Adriana Teixeira, Flávia Carla Meotti,

Environmental Research

2006

101

Melatonin protects against pro‐oxidant enzymes and reduces lipid peroxidation in distinct membranes induced by the hydroxyl and ascorbyl radicals and by peroxynitrite

Adriana Teixeira, Marcos Paulo Morfim, Clarissa Amorim Silva de Cordova,

Journal of Pineal Research

2003

86

Relationship between the action of reactive oxygen and nitrogen species on bilayer membranes and antioxidants

Vânia Rodrigues de Lima, Marcos Paulo Morfim, Adriana Teixeira,

Chemistry and Physics of Lipids

2004

35

Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib–Rituximab Versus Rituximab

Bertrand Coiffier, Weimin Li, Erin D. Henitz,

Clinical Cancer Research

2013

18

A possible role for oxidation stress in lymphoid leukaemias and therapeutic failure

Ana Bela Sarmento‐Ribeiro, Teresa Proença, Isabel Sousa,

Leukemia Research

2012

17

Efficacy and Safety of Retreatment with Bortezomib in Patients with Multiple Myeloma: Interim Results From RETRIEVE, a Prospective International Phase 2 Study.

Maria Teresa Petrucci, Igor W. Blau, Paolo Corradini,

Blood

2009

16

Page 1